Plasmacytoid dendritic cells and the control of herpesvirus infections

Viruses

Volumn 1, Issue 3, 2009, Pages 383-419

  Baranek, Thomas ^a,b,c   Zucchini, Nicolas ^a,b,c   Dalod, Marc ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Herpesvirus type 1; Herpesvirus type 2; Human cytomegalovirus; Immunotherapy; Mouse cytomegalovirus; Plasmacytoid dendritic cell; Type I interferon

Indexed keywords

EID: 77349113387     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v1030383     Document Type: Review

References (173)

1. Schleiss, M.R. Persistent and recurring viral infections: the human herpesviruses. Curr. Probl. Pediatr. Adolesc. Health Care 2009, 39, 7-23.
2. Siegal, F.P.; Kadowaki, N.; Shodell, M.; Fitzgerald-Bocarsly, P.A.; Shah, K.; Ho, S.; Antonenko, S.; Liu, Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284, 1835-1837.
3. Stout-Delgado, H.W.; Yang, X.; Walker, W.E.; Tesar, B.M.; Goldstein, D.R. Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation. J. Immunol. 2008, 181, 6747-6756.
4. Donaghy, H.; Bosnjak, L.; Harman, A.N.; Marsden, V.; Tyring, S.K.; Meng, T.C.; Cunningham, A.L. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J. Virol. 2009, 83, 1952-1961.
5. Cederarv, M.; Soderberg-Naucler, C.; Odeberg, J. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity. Immunobiology 2009, 214, 331-341.
6. Kvale, E.O.; Dalgaard, J.; Lund-Johansen, F.; Rollag, H.; Farkas, L.; Midtvedt, K.; Jahnsen, F.L.; Brinchmann, J.E.; Olweus, J. CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 2006, 107, 2022-2029.
7. Schneider, K.; Meyer-Koenig, U.; Hufert, F.T. Human cytomegalovirus impairs the function of plasmacytoid dendritic cells in lymphoid organs. PLoS One 2008, 3, e3482.
8. Varani, S.; Cederarv, M.; Feld, S.; Tammik, C.; Frascaroli, G.; Landini, M.P.; Soderberg-Naucler, C. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J. Immunol. 2007, 179, 7767-7776.
9. Takemoto, M.; Imasawa, T.; Yamanishi, K.; Mori, Y. Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology 2009, 385, 294-302.
10. de Vries, H.J.; Teunissen, M.B.; Zorgdrager, F.; Picavet, D.; Cornelissen, M. Lichen planus remission is associated with a decrease of human herpes virus type 7 protein expression in plasmacytoid dendritic cells. Arch. Dermatol. Res. 2007, 299, 213-219.
11. Lim, W.H.; Kireta, S.; Russ, G.R.; Coates, P.T. Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood 2007, 109, 1043-1050.
12. Dalod, M.; Salazar-Mather, T.P.; Malmgaard, L.; Lewis, C.; Asselin-Paturel, C.; Briere, F.; Trinchieri, G.; Biron, C.A. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 2002, 195, 517-528.
13. Dalod, M.; Hamilton, T.; Salomon, R.; Salazar-Mather, T.P.; Henry, S.C.; Hamilton, J.D.; Biron, C.A. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 2003, 197, 885-898.
14. Isaacs, A.; Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 1957, 147, 258-267.
15. Theofilopoulos, A.N.; Baccala, R.; Beutler, B.; Kono, D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23, 307-336.
16. Garcia-Sastre, A.; Biron, C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312, 879-882.
17. Aichele, P.; Unsoeld, H.; Koschella, M.; Schweier, O.; Kalinke, U.; Vucikuja, S. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 2006, 176, 4525-4529.
18. Le Bon, A.; Durand, V.; Kamphuis, E.; Thompson, C.; Bulfone-Paus, S.; Rossmann, C.; Kalinke, U.; Tough, D.F. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J. Immunol. 2006, 176, 4682-4689.
19. Martinez, J.; Huang, X.; Yang, Y. Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J. Immunol. 2008, 180, 1592-1597.
20. Kolumam, G.A.; Thomas, S.; Thompson, L.J.; Sprent, J.; Murali-Krishna, K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005, 202, 637-650.
21. Lucas, M.; Schachterle, W.; Oberle, K.; Aichele, P.; Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007, 26, 503-517.
22. Nguyen, K.B.; Salazar-Mather, T.P.; Dalod, M.Y.; Van Deusen, J.B.; Wei, X.Q.; Liew, F.Y.; Caligiuri, M.A.; Durbin, J.E.; Biron, C.A. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 2002, 169, 4279-4287.
23. Honda, K.; Sakaguchi, S.; Nakajima, C.; Watanabe, A.; Yanai, H.; Matsumoto, M.; Ohteki, T.; Kaisho, T.; Takaoka, A.; Akira, S.; Seya, T.; Taniguchi, T. Selective contribution of IFNalpha/ beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc. Natl. Acad. Sci. U S A 2003, 100, 10872-10877.
24. Le Bon, A.; Tough, D.F. Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev. 2008, 19, 33-40.
25. Pestka, S.; Krause, C.D.; Walter, M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 2004, 202, 8-32.
26. Blasius, A.L.; Barchet, W.; Cella, M.; Colonna, M. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J. Exp. Med. 2007, 204, 2561-2568.
27. Caminschi, I.; Ahmet, F.; Heger, K.; Brady, J.; Nutt, S.L.; Vremec, D.; Pietersz, S.; Lahoud, M.H.; Schofield, L.; Hansen, D.S.; O'Keeffe, M.; Smyth, M.J.; Bedoui, S.; Davey, G.M.; Villadangos, J.A.; Heath, W.R.; Shortman, K. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J. Exp. Med. 2007, 204, 2579-2590.
28. Robbins, S.H.; Walzer, T.; Dembele, D.; Thibault, C.; Defays, A.; Bessou, G.; Xu, H.; Vivier, E.; Sellars, M.; Pierre, P.; Sharp, F.R.; Chan, S.; Kastner, P.; Dalod, M. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 2008, 9, R17.
29. Vosshenrich, C.A.; Lesjean-Pottier, S.; Hasan, M.; Richard-Le Goff, O.; Corcuff, E.; Mandelboim, O.; Di Santo, J.P. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med. 2007, 204, 2569-2578.
30. Segura, E.; Wong, J.; Villadangos, J.A. Cutting edge: B220+CCR9-dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells. J. Immunol. 2009, 183, 1514-1517.
31. Liu, Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23, 275-306.
32. Asselin-Paturel, C.; Boonstra, A.; Dalod, M.; Durand, I.; Yessaad, N.; Dezutter-Dambuyant, C.; Vicari, A.; O'Garra, A.; Biron, C.; Briere, F.; Trinchieri, G. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001, 2, 1144-1150.
33. Cella, M.; Jarrossay, D.; Facchetti, F.; Alebardi, O.; Nakajima, H.; Lanzavecchia, A.; Colonna, M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999, 5, 919-923.
34. Nakano, H.; Yanagita, M.; Gunn, M.D. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001, 194, 1171-1178.
35. Bjorck, P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001, 98, 3520-3526.
36. Chehimi, J.; Starr, S.E.; Kawashima, H.; Miller, D.S.; Trinchieri, G.; Perussia, B.; Bandyopadhyay, S. Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood. Immunology 1989, 68, 486-490.
37. Fitzgerald-Bocarsly, P.; Feldman, M.; Mendelsohn, M.; Curl, S.; Lopez, C. Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors. J. Leukoc. Biol. 1988, 43, 323-334.
38. Ito, T.; Kanzler, H.; Duramad, O.; Cao, W.; Liu, Y.J. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 2006, 107, 2423-2431.
39. Krug, A.; French, A.R.; Barchet, W.; Fischer, J.A.; Dzionek, A.; Pingel, J.T.; Orihuela, M.M.; Akira, S.; Yokoyama, W.M.; Colonna, M. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004, 21, 107-119.
40. Rasmussen, S.B.; Sorensen, L.N.; Malmgaard, L.; Ank, N.; Baines, J.D.; Chen, Z.J.; Paludan, S.R. Type I interferon production during herpes simplex virus infection is controlled by cell-typespecific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J. Virol. 2007, 81, 13315-13324.
41. Bozza, S.; Gaziano, R.; Bonifazi, P.; Zelante, T.; Pitzurra, L.; Montagnoli, C.; Moretti, S.; Castronari, R.; Sinibaldi, P.; Rasi, G.; Garaci, E.; Bistoni, F.; Romani, L. Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo. Int. Immunol. 2007, 19, 1261-1270.
42. Andoniou, C.E.; van Dommelen, S.L.; Voigt, V.; Andrews, D.M.; Brizard, G.; Asselin-Paturel, C.; Delale, T.; Stacey, K.J.; Trinchieri, G.; Degli-Esposti, M.A. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 2005, 6, 1011-1019.
43. Zucchini, N.; Bessou, G.; Robbins, S.H.; Chasson, L.; Raper, A.; Crocker, P.R.; Dalod, M. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int. Immunol. 2008, 20, 45-56.
44. Scheu, S.; Dresing, P.; Locksley, R.M. Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl. Acad. Sci. U S A 2008, 105, 20416-20421.
45. Allman, D.; Dalod, M.; Asselin-Paturel, C.; Delale, T.; Robbins, S.H.; Trinchieri, G.; Biron, C.A.; Kastner, P.; Chan, S. Ikaros is required for plasmacytoid dendritic cell differentiation. Blood 2006, 108, 4025-4034.
46. Lund, J.M.; Linehan, M.M.; Iijima, N.; Iwasaki, A. Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J. Immunol. 2006, 177, 7510-7514.
47. Kumagai, Y.; Takeuchi, O.; Kato, H.; Kumar, H.; Matsui, K.; Morii, E.; Aozasa, K.; Kawai, T.; Akira, S. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 2007, 27, 240-252.
48. GeurtsvanKessel, C.H.; Willart, M.A.; van Rijt, L.S.; Muskens, F.; Kool, M.; Baas, C.; Thielemans, K.; Bennett, C.; Clausen, B.E.; Hoogsteden, H.C.; Osterhaus, A.D.; Rimmelzwaan, G.F.; Lambrecht, B.N. Clearance of influenza virus from the lung depends on migratory langerin+CD11b-but not plasmacytoid dendritic cells. J. Exp. Med. 2008, 205, 1621-1634.
49. Wolf, A.I.; Buehler, D.; Hensley, S.E.; Cavanagh, L.L.; Wherry, E.J.; Kastner, P.; Chan, S.; Weninger, W. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. J. Immunol. 2009, 182, 871-879.
50. Johansson, C.; Wetzel, J.D.; He, J.; Mikacenic, C.; Dermody, T.S.; Kelsall, B.L. Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus. J. Exp. Med. 2007, 204, 1349-1358.
51. Contractor, N.; Louten, J.; Kim, L.; Biron, C.A.; Kelsall, B.L. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J. Immunol. 2007, 179, 2690-2694.
52. Steinberg, C.; Eisenacher, K.; Gross, O.; Reindl, W.; Schmitz, F.; Ruland, J.; Krug, A. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection. Eur. J. Immunol. 2009, 39, 1007-1018.
53. Scalzo, A.A.; Yokoyama, W.M. Cmv1 and natural killer cell responses to murine cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 2008, 321, 101-122.
54. Abbo, L.; Vincek, V.; Dickinson, G.; Shrestha, N.; Doblecki, S.; Haslett, P.A. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod. Clin. Infect. Dis. 2007, 44, e25-27.
55. Dalloul, A.; Oksenhendler, E.; Chosidow, O.; Ribaud, P.; Carcelain, G.; Louvet, S.; Massip, P.; Lebon, P.; Autran, B. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. J. Clin. Virol. 2004, 30, 329-336.
56. Kittan, N.A.; Bergua, A.; Haupt, S.; Donhauser, N.; Schuster, P.; Korn, K.; Harrer, T.; Schmidt, B. Impaired plasmacytoid dendritic cell innate immune responses in patients with herpes virusassociated acute retinal necrosis. J. Immunol. 2007, 179, 4219-4230.
57. Zuniga, E.I.; Liou, L.Y.; Mack, L.; Mendoza, M.; Oldstone, M.B. Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. Cell Host Microbe 2008, 4, 374-386.
58. Baranek, T.; Dalod, M. How opportunistic agents benefit from viral infections: the plasmacytoid dendritic cell connection. Cell Host Microbe 2008, 4, 305-307.
59. Nascimbeni, M.; Perie, L.; Chorro, L.; Diocou, S.; Kreitmann, L.; Louis, S.; Garderet, L.; Fabiani, B.; Berger, A.; Schmitz, J.; Marie, J.P.; Molina, T.J.; Pacanowski, J.; Viard, J.P.; Oksenhendler, E.; Beq, S.; Abehsira-Amar, O.; Cheynier, R.; Hosmalin, A. Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferonalpha expression. Blood 2009, 113, 6112-6119.
60. Slyker, J.A.; Lohman-Payne, B.L.; John-Stewart, G.C.; Maleche-Obimbo, E.; Emery, S.; Richardson, B.; Dong, T.; Iversen, A.K.; Mbori-Ngacha, D.; Overbaugh, J.; Emery, V.C.; Rowland-Jones, S.L. Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS 2009, 23, 2173-2181.
61. Gallant, J.E.; Moore, R.D.; Richman, D.D.; Keruly, J.; Chaisson, R.E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J. Infect. Dis. 1992, 166, 1223-1227.
62. Van de Perre, P.; Segondy, M.; Foulongne, V.; Ouedraogo, A.; Konate, I.; Huraux, J.M.; Mayaud, P.; Nagot, N. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect. Dis. 2008, 8, 490-497.
63. Hosmalin, A.; Lebon, P. Type I interferon production in HIV-infected patients. J. Leukoc. Biol. 2006, 80, 984-993.
64. Britt, W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 2008, 325, 417-470.
65. Giraud, S.; Dhedin, N.; Gary-Gouy, H.; Lebon, P.; Vernant, J.P.; Dalloul, A. Plasmacytoid dendritic cell reconstitution following bone marrow transplantation: subnormal recovery and functional deficit of IFN-alpha/beta production in response to herpes simplex virus. J. Interferon Cytokine Res. 2005, 25, 135-143.
66. Abe, M.; Thomson, A.W. Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin. Immunol. 2006, 118, 300-306.
67. Boor, P.P.; Metselaar, H.J.; Mancham, S.; Tilanus, H.W.; Kusters, J.G.; Kwekkeboom, J. Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells. Am. J. Transplant. 2006, 6, 2332-2341.
68. Cisse, B.; Caton, M.L.; Lehner, M.; Maeda, T.; Scheu, S.; Locksley, R.; Holmberg, D.; Zweier, C.; den Hollander, N.S.; Kant, S.G.; Holter, W.; Rauch, A.; Zhuang, Y.; Reizis, B. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008, 135, 37-48.
69. Megjugorac, N.J.; Young, H.A.; Amrute, S.B.; Olshalsky, S.L.; Fitzgerald-Bocarsly, P. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. J. Leukoc. Biol. 2004, 75, 504-514.
70. Salazar-Mather, T.P.; Hokeness, K.L. Cytokine and chemokine networks: pathways to antiviral defense. Curr. Top. Microbiol. Immunol. 2006, 303, 29-46.
71. Fehniger, T.A.; Cai, S.F.; Cao, X.; Bredemeyer, A.J.; Presti, R.M.; French, A.R.; Ley, T.J. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 2007, 26, 798-811.
72. Mortier, E.; Woo, T.; Advincula, R.; Gozalo, S.; Ma, A. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 2008, 205, 1213-1225.
73. Barr, D.P.; Belz, G.T.; Reading, P.C.; Wojtasiak, M.; Whitney, P.G.; Heath, W.R.; Carbone, F.R.; Brooks, A.G. A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection. Eur. J. Immunol. 2007, 37, 1334-1342.
74. Decalf, J.; Fernandes, S.; Longman, R.; Ahloulay, M.; Audat, F.; Lefrerre, F.; Rice, C.M.; Pol, S.; Albert, M.L. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J. Exp. Med. 2007, 204, 2423-2437.
75. Piqueras, B.; Connolly, J.; Freitas, H.; Palucka, A.K.; Banchereau, J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006, 107, 2613-2618.
76. Hanabuchi, S.; Watanabe, N.; Wang, Y.H.; Ito, T.; Shaw, J.; Cao, W.; Qin, F.X.; Liu, Y.J. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 2006, 107, 3617-3623.
77. Pichlmair, A.; Reis e Sousa, C. Innate recognition of viruses. Immunity 2007, 27, 370-383.
78. Cervantes-Barragan, L.; Zust, R.; Weber, F.; Spiegel, M.; Lang, K.S.; Akira, S.; Thiel, V.; Ludewig, B. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 2007, 109, 1131-1137.
79. Cervantes-Barragan, L.; Kalinke, U.; Zust, R.; Konig, M.; Reizis, B.; Lopez-Macias, C.; Thiel, V.; Ludewig, B. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 2009, 182, 1099-1106.
80. Crozat, K.; Vivier, E.; Dalod, M. Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies. Immunol. Rev. 2009, 227, 129-149.
81. Barton, G.M.; Kagan, J.C.; Medzhitov, R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 2006, 7, 49-56.
82. Megjugorac, N.J.; Jacobs, E.S.; Izaguirre, A.G.; George, T.C.; Gupta, G.; Fitzgerald-Bocarsly, P. Image-based study of interferongenic interactions between plasmacytoid dendritic cells and HSVinfected monocyte-derived dendritic cells. Immunol. Invest. 2007, 36, 739-761.
83. Lund, J.; Sato, A.; Akira, S.; Medzhitov, R.; Iwasaki, A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 2003, 198, 513-520.
84. Delale, T.; Paquin, A.; Asselin-Paturel, C.; Dalod, M.; Brizard, G.; Bates, E.E.; Kastner, P.; Chan, S.; Akira, S.; Vicari, A.; Biron, C.A.; Trinchieri, G.; Briere, F. MyD88-dependent and-independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. J. Immunol. 2005, 175, 6723-6732.
85. Krug, A.; Luker, G.D.; Barchet, W.; Leib, D.A.; Akira, S.; Colonna, M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103, 1433-1437.
86. Schneider, K.; Loewendorf, A.; De Trez, C.; Fulton, J.; Rhode, A.; Shumway, H.; Ha, S.; Patterson, G.; Pfeffer, K.; Nedospasov, S.A.; Ware, C.F.; Benedict, C.A. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 2008, 3, 67-76.
87. Rebsamen, M.; Heinz, L.X.; Meylan, E.; Michallet, M.C.; Schroder, K.; Hofmann, K.; Vazquez, J.; Benedict, C.A.; Tschopp, J. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep. 2009, 10, 916-922.
88. Samanta, M.; Iwakiri, D.; Kanda, T.; Imaizumi, T.; Takada, K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 2006, 25, 4207-4214.
89. Zucchini, N.; Bessou, G.; Traub, S.; Robbins, S.H.; Uematsu, S.; Akira, S.; Alexopoulou, L.; Dalod, M. Cutting edge: Overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J. Immunol. 2008, 180, 5799-5803.
90. Mancuso, G.; Gambuzza, M.; Midiri, A.; Biondo, C.; Papasergi, S.; Akira, S.; Teti, G.; Beninati, C. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 2009, 10, 587-594.
91. Fukui, R.; Saitoh, S.; Matsumoto, F.; Kozuka-Hata, H.; Oyama, M.; Tabeta, K.; Beutler, B.; Miyake, K. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA-but against RNA-sensing. J. Exp. Med. 2009, 206, 1339-1350.
92. Honda, K.; Yanai, H.; Negishi, H.; Asagiri, M.; Sato, M.; Mizutani, T.; Shimada, N.; Ohba, Y.; Takaoka, A.; Yoshida, N.; Taniguchi, T. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 2005, 434, 772-777.
93. Levy, D.E.; Marie, I.; Smith, E.; Prakash, A. Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J. Interferon Cytokine Res. 2002, 22, 87-93.
94. Guiducci, C.; Ott, G.; Chan, J.H.; Damon, E.; Calacsan, C.; Matray, T.; Lee, K.D.; Coffman, R.L.; Barrat, F.J. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 2006, 203, 1999-2008.
95. Honda, K.; Ohba, Y.; Yanai, H.; Negishi, H.; Mizutani, T.; Takaoka, A.; Taya, C.; Taniguchi, T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005, 434, 1035-1040.
96. Barchet, W.; Cella, M.; Odermatt, B.; Asselin-Paturel, C.; Colonna, M.; Kalinke, U. Virusinduced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 2002, 195, 507-516.
97. Kumagai, Y.; Kumar, H.; Koyama, S.; Kawai, T.; Takeuchi, O.; Akira, S. Cutting Edge: TLRDependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells. J. Immunol. 2009, 182, 3960-3964.
98. Diebold, S.S.; Montoya, M.; Unger, H.; Alexopoulou, L.; Roy, P.; Haswell, L.E.; Al-Shamkhani, A.; Flavell, R.; Borrow, P.; Reis e Sousa, C. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003, 424, 324-328.
99. DeFilippis, V.R. Induction and evasion of the type I interferon response by cytomegaloviruses. Adv. Exp. Med. Biol. 2007, 598, 309-324.
100. Hengel, H.; Koszinowski, U.H.; Conzelmann, K.K. Viruses know it all: new insights into IFN networks. Trends Immunol. 2005, 26, 396-401.
101. Bowie, A.G.; Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008, 8, 911-922.
102. Chang, W.L.; Barry, P.A.; Szubin, R.; Wang, D.; Baumgarth, N. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 2009, 390, 330-337.
103. Banchereau, J.; Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006, 25, 383-392.
104. Conrad, C.; Meller, S.; Gilliet, M. Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids. Semin. Immunol. 2009, 21, 101-109.
105. Nestle, F.O.; Conrad, C.; Tun-Kyi, A.; Homey, B.; Gombert, M.; Boyman, O.; Burg, G.; Liu, Y.J.; Gilliet, M. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 2005, 202, 135-143.
106. Cao, W.; Rosen, D.B.; Ito, T.; Bover, L.; Bao, M.; Watanabe, G.; Yao, Z.; Zhang, L.; Lanier, L.L.; Liu, Y.J. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Tolllike receptor-induced interferon production. J. Exp. Med. 2006, 203, 1399-1405.
107. Rock, J.; Schneider, E.; Grun, J.R.; Grutzkau, A.; Kuppers, R.; Schmitz, J.; Winkels, G. CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2. Eur. J. Immunol. 2007, 37, 3564-3575.
108. Cao, W.; Zhang, L.; Rosen, D.B.; Bover, L.; Watanabe, G.; Bao, M.; Lanier, L.L.; Liu, Y.J. BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol. 2007, 5, e248.
109. Blasius, A.; Vermi, W.; Krug, A.; Facchetti, F.; Cella, M.; Colonna, M. A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha. Blood 2004, 103, 4201-4206.
110. Blasius, A.L.; Cella, M.; Maldonado, J.; Takai, T.; Colonna, M. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 2006, 107, 2474-2476.
111. Sjolin, H.; Robbins, S.H.; Bessou, G.; Hidmark, A.; Tomasello, E.; Johansson, M.; Hall, H.; Charifi, F.; Karlsson Hedestam, G.B.; Biron, C.A.; Karre, K.; Hoglund, P.; Vivier, E.; Dalod, M. DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J. Immunol. 2006, 177, 2908-2916.
112. Blasius, A.L.; Giurisato, E.; Cella, M.; Schreiber, R.D.; Shaw, A.S.; Colonna, M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 2006, 177, 3260-3265.
113. Rothlin, C.V.; Ghosh, S.; Zuniga, E.I.; Oldstone, M.B.; Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007, 131, 1124-1136.
114. Meyer-Wentrup, F.; Benitez-Ribas, D.; Tacken, P.J.; Punt, C.J.; Figdor, C.G.; de Vries, I.J.; Adema, G.J. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 2008, 111, 4245-4253.
115. Zhang, J.; Raper, A.; Sugita, N.; Hingorani, R.; Salio, M.; Palmowski, M.J.; Cerundolo, V.; Crocker, P.R. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 2006, 107, 3600-3608.
116. Robbins, S.H.; Bessou, G.; Cornillon, A.; Zucchini, N.; Rupp, B.; Ruzsics, Z.; Sacher, T.; Tomasello, E.; Vivier, E.; Koszinowski, U.H.; Dalod, M. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 2007, 3, e123.
117. Villadangos, J.A.; Young, L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008, 29, 352-361.
118. Young, L.J.; Wilson, N.S.; Schnorrer, P.; Proietto, A.; ten Broeke, T.; Matsuki, Y.; Mount, A.M.; Belz, G.T.; O'Keeffe, M.; Ohmura-Hoshino, M.; Ishido, S.; Stoorvogel, W.; Heath, W.R.; Shortman, K.; Villadangos, J.A. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 2008, 9, 1244-1252.
119. Sadaka, C.; Marloie-Provost, M.A.; Soumelis, V.; Benaroch, P. Developmental regulation of MHC II expression and transport in human plasmacytoid-derived dendritic cells. Blood 2009, 113, 2127-2135.
120. Hoeffel, G.; Ripoche, A.C.; Matheoud, D.; Nascimbeni, M.; Escriou, N.; Lebon, P.; Heshmati, F.; Guillet, J.G.; Gannage, M.; Caillat-Zucman, S.; Casartelli, N.; Schwartz, O.; De la Salle, H.; Hanau, D.; Hosmalin, A.; Maranon, C. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007, 27, 481-492.
121. Mouries, J.; Moron, G.; Schlecht, G.; Escriou, N.; Dadaglio, G.; Leclerc, C. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood 2008, 112, 3713-3722.
122. Di Pucchio, T.; Chatterjee, B.; Smed-Sorensen, A.; Clayton, S.; Palazzo, A.; Montes, M.; Xue, Y.; Mellman, I.; Banchereau, J.; Connolly, J.E. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 2008, 9, 551-557.
123. Yoneyama, H.; Matsuno, K.; Toda, E.; Nishiwaki, T.; Matsuo, N.; Nakano, A.; Narumi, S.; Lu, B.; Gerard, C.; Ishikawa, S.; Matsushima, K. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 2005, 202, 425-435.
124. Yoneyama, H.; Matsuno, K.; Zhang, Y.; Nishiwaki, T.; Kitabatake, M.; Ueha, S.; Narumi, S.; Morikawa, S.; Ezaki, T.; Lu, B.; Gerard, C.; Ishikawa, S.; Matsushima, K. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 2004, 16, 915-928.
125. Jego, G.; Palucka, A.K.; Blanck, J.P.; Chalouni, C.; Pascual, V.; Banchereau, J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003, 19, 225-234.
126. Kawamura, K.; Kadowaki, N.; Kitawaki, T.; Uchiyama, T. Virus-stimulated plasmacytoid dendritic cells induce CD4+ cytotoxic regulatory T cells. Blood 2006, 107, 1031-1038.
127. Kvale, E.O.; Floisand, Y.; Lund-Johansen, F.; Rollag, H.; Farkas, L.; Ghanekar, S.; Brandtzaeg, P.; Jahnsen, F.L.; Olweus, J. Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells. Blood 2007, 109, 3369-3376.
128. Fallarino, F.; Asselin-Paturel, C.; Vacca, C.; Bianchi, R.; Gizzi, S.; Fioretti, M.C.; Trinchieri, G.; Grohmann, U.; Puccetti, P. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 2004, 173, 3748-3754.
129. Mellor, A.L.; Baban, B.; Chandler, P.R.; Manlapat, A.; Kahler, D.J.; Munn, D.H. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J. Immunol. 2005, 175, 5601-5605.
130. Sharma, M.D.; Baban, B.; Chandler, P.; Hou, D.Y.; Singh, N.; Yagita, H.; Azuma, M.; Blazar, B.R.; Mellor, A.L.; Munn, D.H. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 2007, 117, 2570-2582.
131. Boasso, A.; Herbeuval, J.P.; Hardy, A.W.; Anderson, S.A.; Dolan, M.J.; Fuchs, D.; Shearer, G.M. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007, 109, 3351-3359.
132. Manches, O.; Munn, D.; Fallahi, A.; Lifson, J.; Chaperot, L.; Plumas, J.; Bhardwaj, N. HIVactivated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenasedependent mechanism. J. Clin. Invest. 2008, 118, 3431-3439.
133. Rolle, A.; Olweus, J. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures. APMIS 2009, 117, 413-426.
134. Lund, J.M.; Hsing, L.; Pham, T.T.; Rudensky, A.Y. Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008, 320, 1220-1224.
135. Ronnblom, L.; Eloranta, M.L.; Alm, G.V. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 2003, 36, 463-472.
136. Stacey, A.R.; Norris, P.J.; Qin, L.; Haygreen, E.A.; Taylor, E.; Heitman, J.; Lebedeva, M.; DeCamp, A.; Li, D.; Grove, D.; Self, S.G.; Borrow, P. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 2009, 83, 3719-3733.
137. Hyrcza, M.D.; Kovacs, C.; Loutfy, M.; Halpenny, R.; Heisler, L.; Yang, S.; Wilkins, O.; Ostrowski, M.; Der, S.D. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J. Virol. 2007, 81, 3477-3486.
138. Mandl, J.N.; Barry, A.P.; Vanderford, T.H.; Kozyr, N.; Chavan, R.; Klucking, S.; Barrat, F.J.; Coffman, R.L.; Staprans, S.I.; Feinberg, M.B. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat. Med. 2008, 14, 1077-1087.
139. Boasso, A.; Shearer, G.M.; Chougnet, C. Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? J. Intern. Med. 2009, 265, 78-96.
140. Lehmann, C.; Harper, J.M.; Taubert, D.; Hartmann, P.; Fatkenheuer, G.; Jung, N.; van Lunzen, J.; Stellbrink, H.J.; Gallo, R.C.; Romerio, F. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 2008, 48, 522-530.
141. Meier, A.; Chang, J.J.; Chan, E.S.; Pollard, R.B.; Sidhu, H.K.; Kulkarni, S.; Wen, T.F.; Lindsay, R.J.; Orellana, L.; Mildvan, D.; Bazner, S.; Streeck, H.; Alter, G.; Lifson, J.D.; Carrington, M.; Bosch, R.J.; Robbins, G.K.; Altfeld, M. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat. Med. 2009.
142. Diop, O.M.; Ploquin, M.J.; Mortara, L.; Faye, A.; Jacquelin, B.; Kunkel, D.; Lebon, P.; Butor, C.; Hosmalin, A.; Barre-Sinoussi, F.; Muller-Trutwin, M.C. Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome. J. Virol. 2008, 82, 5145-5152.
143. Riviere, Y.; Gresser, I.; Guillon, J.C.; Tovey, M.G. Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc. Natl. Acad. Sci. U S A 1977, 74, 2135-2139.
144. Yen, J.H.; Ganea, D. Interferon beta induces mature dendritic cell apoptosis through caspase-11 / caspase-3 activation. Blood 2009, 114, 1344-1354.
145. Hahm, B.; Trifilo, M.J.; Zuniga, E.I.; Oldstone, M.B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 2005, 22, 247-257.
146. Binder, D.; Fehr, J.; Hengartner, H.; Zinkernagel, R.M. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 1997, 185, 517-530.
147. Lin, Q.; Dong, C.; Cooper, M.D. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 1998, 187, 79-87.
148. Bahl, K.; Kim, S.K.; Calcagno, C.; Ghersi, D.; Puzone, R.; Celada, F.; Selin, L.K.; Welsh, R.M. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J. Immunol. 2006, 176, 4284-4295.
149. Gil, M.P.; Salomon, R.; Louten, J.; Biron, C.A. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 2006, 107, 987-993.
150. Le Bon, A.; Schiavoni, G.; D'Agostino, G.; Gresser, I.; Belardelli, F.; Tough, D.F. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001, 14, 461-470.
151. Le Bon, A.; Thompson, C.; Kamphuis, E.; Durand, V.; Rossmann, C.; Kalinke, U.; Tough, D.F. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 2006, 176, 2074-2078.
152. Navarini, A.A.; Recher, M.; Lang, K.S.; Georgiev, P.; Meury, S.; Bergthaler, A.; Flatz, L.; Bille, J.; Landmann, R.; Odermatt, B.; Hengartner, H.; Zinkernagel, R.M. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl. Acad. Sci. U S A 2006, 103, 15535-15539.
153. Shahangian, A.; Chow, E.K.; Tian, X.; Kang, J.R.; Ghaffari, A.; Liu, S.Y.; Belperio, J.A.; Cheng, G.; Deng, J.C. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 2009, 119, 1910-1920.
154. Iversen, A.C.; Steinkjer, B.; Nilsen, N.; Bohnhorst, J.; Moen, S.H.; Vik, R.; Stephens, P.; Thomas, D.W.; Benedict, C.A.; Espevik, T. A proviral role for CpG in cytomegalovirus infection. J. Immunol. 2009, 182, 5672-5681.
155. Li, Q.; Skinner, P.J.; Ha, S.J.; Duan, L.; Mattila, T.L.; Hage, A.; White, C.; Barber, D.L.; O'Mara, L.; Southern, P.J.; Reilly, C.S.; Carlis, J.V.; Miller, C.J.; Ahmed, R.; Haase, A.T. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 2009, 323, 1726-1729.
156. Orange, J.S.; Salazar-Mather, T.P.; Opal, S.M.; Biron, C.A. Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J. Virol. 1997, 71, 9248-9258.
157. Banchereau, J.; Pascual, V.; Palucka, A.K. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004, 20, 539-550.
158. Harley, J.B.; Harley, I.T.; Guthridge, J.M.; James, J.A. The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 2006, 15, 768-777.
159. Posnett, D.N. Herpesviruses and autoimmunity. Curr. Opin. Investig. Drugs 2008, 9, 505-514.
160. Shen, H.; Iwasaki, A. A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicide. J. Clin. Invest. 2006, 116, 2237-2243.
161. Martinez, V.; Molina, J.M.; Scieux, C.; Ribaud, P.; Morfin, F. Topical imiquimod for recurrent acyclovir-resistant HSV infection. Am. J. Med. 2006, 119, e9-11.
162. Vollstedt, S.; Franchini, M.; Hefti, H.P.; Odermatt, B.; O'Keeffe, M.; Alber, G.; Glanzmann, B.; Riesen, M.; Ackermann, M.; Suter, M. Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J. Exp. Med. 2003, 197, 575-584.
163. Li, Q.; Estes, J.D.; Schlievert, P.M.; Duan, L.; Brosnahan, A.J.; Southern, P.J.; Reilly, C.S.; Peterson, M.L.; Schultz-Darken, N.; Brunner, K.G.; Nephew, K.R.; Pambuccian, S.; Lifson, J.D.; Carlis, J.V.; Haase, A.T. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 458, 1034-1038.
164. Guiducci, C.; Coffman, R.L.; Barrat, F.J. Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. J. Intern. Med. 2009, 265, 43-57.
165. Aldridge, J.R., Jr.; Moseley, C.E.; Boltz, D.A.; Negovetich, N.J.; Reynolds, C.; Franks, J.; Brown, S.A.; Doherty, P.C.; Webster, R.G.; Thomas, P.G. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. U S A 2009, 106, 5306-5311.
166. Querec, T.; Bennouna, S.; Alkan, S.; Laouar, Y.; Gorden, K.; Flavell, R.; Akira, S.; Ahmed, R.; Pulendran, B. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 2006, 203, 413-424.
167. Karrer, U.; Sierro, S.; Wagner, M.; Oxenius, A.; Hengel, H.; Koszinowski, U.H.; Phillips, R.E.; Klenerman, P. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J. Immunol. 2003, 170, 2022-2029.
168. Simon, C.O.; Holtappels, R.; Tervo, H.M.; Bohm, V.; Daubner, T.; Oehrlein-Karpi, S.A.; Kuhnapfel, B.; Renzaho, A.; Strand, D.; Podlech, J.; Reddehase, M.J.; Grzimek, N.K. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J. Virol. 2006, 80, 10436-10456.
169. Karrer, U.; Wagner, M.; Sierro, S.; Oxenius, A.; Hengel, H.; Dumrese, T.; Freigang, S.; Koszinowski, U.H.; Phillips, R.E.; Klenerman, P. Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J. Virol. 2004, 78, 2255-2264.
170. Hansen, S.G.; Vieville, C.; Whizin, N.; Coyne-Johnson, L.; Siess, D.C.; Drummond, D.D.; Legasse, A.W.; Axthelm, M.K.; Oswald, K.; Trubey, C.M.; Piatak, M., Jr.; Lifson, J.D.; Nelson, J.A.; Jarvis, M.A.; Picker, L.J. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 2009, 15, 293-299.
171. Casrouge, A.; Zhang, S.Y.; Eidenschenk, C.; Jouanguy, E.; Puel, A.; Yang, K.; Alcais, A.; Picard, C.; Mahfoufi, N.; Nicolas, N.; Lorenzo, L.; Plancoulaine, S.; Senechal, B.; Geissmann, F.; Tabeta, K.; Hoebe, K.; Du, X.; Miller, R.L.; Heron, B.; Mignot, C.; de Villemeur, T.B.; Lebon, P.; Dulac, O.; Rozenberg, F.; Beutler, B.; Tardieu, M.; Abel, L.; Casanova, J.L. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006, 314, 308-312.
172. Yang, K.; Puel, A.; Zhang, S.; Eidenschenk, C.; Ku, C.L.; Casrouge, A.; Picard, C.; von Bernuth, H.; Senechal, B.; Plancoulaine, S.; Al-Hajjar, S.; Al-Ghonaium, A.; Marodi, L.; Davidson, D.; Speert, D.; Roifman, C.; Garty, B.Z.; Ozinsky, A.; Barrat, F.J.; Coffman, R.L.; Miller, R.L.; Li, X.; Lebon, P.; Rodriguez-Gallego, C.; Chapel, H.; Geissmann, F.; Jouanguy, E.; Casanova, J.L. Human TLR-7-,-8-, and-9-mediated induction of IFN-alpha/beta and-lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005, 23, 465-478.
173. Barreiro, L.B.; Ben-Ali, M.; Quach, H.; Laval, G.; Patin, E.; Pickrell, J.K.; Bouchier, C.; Tichit, M.; Neyrolles, O.; Gicquel, B.; Kidd, J.R.; Kidd, K.K.; Alcais, A.; Ragimbeau, J.; Pellegrini, S.; Abel, L.; Casanova, J.L.; Quintana-Murci, L. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet. 2009, 5, e1000562.